RSS Feeds
Search

Articles

Pharmalicensing brings you advice, commentary and analysis from industry experts.

Articles

No results found for given criteria.
Please try to put more general criteria into your selection.

Related Reports

Market Research Reports provided by reports.iptechex.com
Oral Herpes - Pipeline Review, Q4 2010
Nov 2010 - 50 pages - $500
Advanced Oral & Parenteral Drug Delivery Technologies Players, Products & Prospects to 2015
Jan 2011 - 124 pages - $1,740
Herpes Simplex Virus Infection Therapy Area Pipeline Report
Nov 2010 - 245 pages - $1,495
Herpes Labialis (Oral Herpes) - Pipeline Review, Q2 2011
May 2011 - 42 pages - $500
Oral Hygiene Market - Regional level to 2011
May 2008 - 85 pages - $1,995
Herpes Simplex Therapeutics - Pipeline Assessment and Market Forecasts to 2018
Sep 2011 - 76 pages - $3,500
Drug Delivery Markets, Vol I: Oral Delivery
Jan 2007 - 126 pages - $2,495
Leading Drug Delivery Companies and Technologies
Jun 2008 - 175 pages - $3,835
Victrelis (boceprevir) - First-in-Class Oral Hepatitis C Virus (HCV) Protease Inhibitor Approved in The US and Telaprevir to Follow
May 2011 - 6 pages - $500
Benchmarking the Pharmaceutical Market by Drug Delivery to 2014
Dec 2009 - 84 pages - $7,600
More Related Market Research Reports >>>

Your selection

Industry sector
Drug delivery del
Topical del
Oral del
Lotion del
Therapeutic target
Oral Health del
Herpes simplex virus type 1 (oral) del
Year
2001 del

Clients in focus...

Get the Flash Player to see this rotator.

© Copyright 1998-2013 IP Technology Exchange, Inc All rights reserved. Terms and Conditions | Contact us